A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Unless otherwise noted, "we," "us," "our," "Claritev," and the "Company" and similar terms refer to Claritev Corporation and its subsidiaries. Information concerning shares of our Class A common stock has been adjusted to reflect the 1-for-40 reverse split of our Class A common stock that was made effective on September 20, 2024. Our Business and Market Opportunity Claritev Corporation is a technology, data and insights company focused on improving transparency, affordability and quality across the healthcare system. Claritev brings objective, market-based insights to some of the healthcare system's most complex decisions - grounded in decades of claims experience. By applying data, analytics and experience, Claritev helps organizations across the healthcare ecosystem better understand costs, pricing and payment dynamics.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 965M | 965M | 931M | 962M | 1.1B | 1.1B |
| Net Income | -284M | -284M | -1.6B | -92M | -573M | 102M |
| EPS | $-17.30 | $-17.30 | $-101.92 | $-5.69 | $-36.00 | $6.40 |
| Free Cash Flow | -12M | -12M | -11M | 63M | 283M | 320M |
| ROIC | 0.5% | 0.6% | -35.8% | 2.6% | -8.8% | 4.2% |
| Gross Margin | 73.8% | 73.8% | 74.3% | 75.5% | 81.1% | 84.3% |
| Debt/Equity | 0.00 | -26.39 | 53.99 | 2.67 | 2.66 | 2.09 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 29M | 29M | -1.4B | 162M | -363M | 386M |
| Operating Margin | 3.0% | 3.0% | -149.4% | 16.8% | -33.6% | 34.5% |
| ROE | 0.0% | - | -1958.8% | -5.4% | -32.0% | 4.4% |
| Shares Outstanding | 16M | 16M | 16M | 16M | 16M | 16M |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 1.0B | 983M | 938M | 1.1B | 1.1B | 962M | 931M | 965M | 965M |
| Gross Margin | 85.6% | 84.8% | 66.0% | 84.3% | 81.1% | 75.5% | 74.3% | 73.8% | 73.8% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 222K | 288K | 356M | 151M | 167M | 144M | 151M | 222M | 222M |
| EBIT | 428M | 368M | -132M | 386M | -363M | 162M | -1.4B | 29M | 29M |
| Op. Margin | 41.1% | 37.5% | -14.1% | 34.5% | -33.6% | 16.8% | -149.4% | 3.0% | 3.0% |
| Net Income | 36M | 9.7M | -521M | 102M | -573M | -92M | -1.6B | -284M | -284M |
| Net Margin | 3.5% | 1.0% | -55.5% | 9.1% | -53.1% | -9.5% | -176.9% | -29.4% | -29.4% |
| Non-Recurring | -2.2M | -163K | 0 | 0 | 662M | 0 | 1.5B | -9.4M | -9.4M |
| Returns on Capital | |||||||||
| ROIC | N/A | 7.7% | -1.9% | 4.2% | -8.8% | 2.6% | -35.8% | 0.6% | 0.5% |
| ROE | N/A | 0.5% | -20.4% | 4.4% | -32.0% | -5.4% | -1958.8% | N/A | 0.0% |
| ROA | 10.8% | 0.2% | -6.3% | 1.2% | -7.8% | -1.3% | -32.0% | -5.7% | -5.8% |
| Cash Flow | |||||||||
| Op. Cash Flow | 292M | 284M | 377M | 405M | 372M | 172M | 108M | 117M | 117M |
| Free Cash Flow | 229M | 218M | 307M | 320M | 283M | 63M | -11M | -12M | -12M |
| Owner Earnings | 138M | 120M | -89M | 322M | 287M | 76M | -7.2M | -12M | -12M |
| CapEx | 64M | 66M | 71M | 85M | 90M | 109M | 118M | 130M | 130M |
| Maint. CapEx | 149M | 150M | 61M | 65M | 69M | 77M | 88M | 102M | 102M |
| Growth CapEx | 0 | 0 | 10M | 20M | 21M | 32M | 30M | 28M | 28M |
| D&A | 149M | 150M | 61M | 65M | 69M | 77M | 88M | 102M | 102M |
| CapEx/OCF | N/A | N/A | 18.8% | 20.9% | 24.1% | 63.4% | 109.8% | 110.5% | 110.5% |
| Capital Allocation | |||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 101M | 100M | 0 | 15M | 10M | 0 | 0 |
| Buyback Yield | N/A | N/A | 2.5% | 3.6% | N/A | 1.4% | 3.7% | N/A | 0.0% |
| Stock-Based Comp | 4.7M | 15M | 406M | 18M | 17M | 18M | 27M | 28M | 28M |
| Debt Repayment | 0 | 0 | 23M | 0 | 0 | 0 | 615K | 4.3M | 4.3M |
| Balance Sheet | |||||||||
| Net Debt | 240M | 5.4B | 4.3B | 4.5B | 4.1B | 4.4B | 4.5B | 4.6B | 4.6B |
| Cash & Equiv. | 5.0M | 22M | 127M | 185M | 334M | 72M | 17M | 17M | 17M |
| Long-Term Debt | N/A | 5.4B | 4.6B | 4.9B | 4.7B | 4.5B | 4.5B | 4.6B | 4.6B |
| Debt/Equity | N/A | 2.72 | 1.79 | 2.09 | 2.66 | 2.67 | 53.99 | -26.39 | 0.00 |
| Interest Coverage | 1.1 | 1.0 | -0.4 | 1.4 | -1.2 | 0.5 | -4.3 | 0.1 | 0.1 |
| Equity | N/A | 2.0B | 2.6B | 2.3B | 1.8B | 1.7B | 84M | -174M | -174M |
| Total Assets | 334M | 8.4B | 8.3B | 8.2B | 7.4B | 7.0B | 5.2B | 4.9B | 4.9B |
| Total Liabilities | N/A | 6.4B | 5.7B | 5.9B | 5.6B | 5.3B | 5.1B | 5.1B | 5.1B |
| Intangibles | N/A | 8.0B | 7.8B | 7.6B | 6.6B | 6.5B | 4.6B | 4.3B | 4.3B |
| Retained Earnings | N/A | 638M | 117M | 225M | -348M | -499M | -2.1B | -2.4B | -2.4B |
| Working Capital | N/A | 30M | 96M | 177M | 271M | 27M | -38M | -37M | -37M |
| Current Assets | N/A | 116M | 209M | 319M | 447M | 194M | 176M | 224M | 224M |
| Current Liabilities | N/A | 86M | 112M | 142M | 176M | 167M | 214M | 261M | 261M |
| Per Share Data | |||||||||
| EPS | 3.60 | 0.80 | -44.40 | 6.40 | -36.00 | -5.69 | -101.92 | -17.30 | -17.30 |
| Owner EPS | 13.73 | 9.87 | -7.61 | 20.18 | 18.03 | 4.74 | -0.45 | -0.74 | -0.74 |
| Book Value | N/A | 163.56 | 218.17 | 147.00 | 112.51 | 106.05 | 5.20 | -10.58 | -10.58 |
| Cash Flow/Share | 29.05 | 23.42 | 32.19 | 25.37 | 23.40 | 10.66 | 6.66 | 7.14 | -11.11 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 10.1M | 12.1M | 11.7M | 15.9M | 15.9M | 16.1M | 16.1M | 16.4M | 16.4M |
| Valuation | |||||||||
| P/E Ratio | N/A | N/A | N/A | 27.5 | N/A | N/A | N/A | N/A | -1.0 |
| P/FCF | N/A | N/A | 13.4 | 8.8 | 2.7 | 16.8 | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | 19.0 | N/A | 33.8 | N/A | 182.4 | 169.3 |
| Price/Book | N/A | N/A | 1.6 | 1.2 | 0.4 | 0.6 | 3.4 | N/A | N/A |
| Price/Sales | N/A | N/A | 4.9 | 3.8 | 2.3 | 1.0 | 0.4 | 0.7 | 0.3 |
| FCF Yield | N/A | N/A | 7.5% | 11.4% | 37.6% | 5.9% | -3.7% | -1.8% | -4.1% |
| Market Cap | N/A | N/A | 4.1B | 2.8B | 751M | 1.1B | 283M | 691M | 298M |
| Avg. Price | N/A | N/A | 392.36 | 263.31 | 152.92 | 58.23 | 21.57 | 38.82 | 18.14 |
| Year-End Price | N/A | N/A | 349.60 | 176.00 | 47.20 | 65.60 | 17.52 | 42.03 | 18.14 |
Claritev Corp passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 77.8%. At current prices, the estimated annualized return to fair value is -31.5%.
Claritev Corp (CTEV) has a 5-year average return on invested capital (ROIC) of -7.4%. This is below average and may indicate limited pricing power.
Claritev Corp (CTEV) has a market capitalization of $298M. It is classified as a small-cap stock.
Claritev Corp (CTEV) does not currently pay a regular dividend.
Claritev Corp (CTEV) operates in the Services-Business Services, Nec industry, within the Industrials sector.
Claritev Corp (CTEV) reported annual revenue of $965 million in its most recent fiscal year, based on SEC EDGAR filings.
Claritev Corp (CTEV) has a net profit margin of -29.4%. The company is currently unprofitable.
Claritev Corp (CTEV) generated $-12 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Claritev Corp (CTEV) reported earnings per share (EPS) of $-17.30 in its most recent fiscal year.
Claritev Corp (CTEV) has a 5-year average gross margin of 77.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 8 years of financial data for Claritev Corp (CTEV), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Claritev Corp (CTEV) has a book value per share of $-10.58, based on its most recent annual SEC filing.
No recent press releases.